薬剤比較
Tirzepatide vs Acarbose
Tirzepatide (Mounjaro) vs Acarbose (Precose) for T2D: Dual GIP/GLP-1 injection vs oral alpha-glucosidase inhibitor. Tirzepatide superior for A1C and weight; Acarbose milder oral option.
このページには比較できる項目がありません。
臨床的背景
Patients with type 2 diabetes comparing an injectable dual GIP/GLP-1 agonist against a traditional oral alpha-glucosidase inhibitor for glycemic control and weight management.
結論
Tirzepatide typically delivers greater A1C reduction and weight loss than Acarbose, but administration route and safety profile influence individual suitability.
すべての薬剤比較